Overview of Technological Advances in Cancer Therapy

(University of Bern, September 01, 2022)

A team of researchers led by Dr. Dilara Akhoundova and Professor Mark Rubin form the University of Bern and the Insel Gruppe recently published an insightful overview of the latest advances in multi-omics tumor profiling, thereby not only providing a critical analysis of the current stages of the translational validation of these technologies, but also a stimulating discussion of future perspectives for their integration into precision treatment. This is an exciting development, because despite their promising potential, there are still a number of hurdles to overcome before these groundbreaking technologies can be used in the clinic. For example, they still need to be standardized, require regulatory approval, as well as often necessitate clinics to update their infrastructure in order to be able to evaluate the significant volume of data generated.